Patient-Specific Pluripotent Stem Cells in Neurological Diseases
Author Information
Author(s): Durnaoglu Serpen, Genc Sermin, Genc Kursad
Primary Institution: Dokuz Eylul University
Hypothesis
The study explores the potential of patient-specific induced pluripotent stem cells (iPSCs) for modeling and treating neurological diseases.
Conclusion
Patient-specific iPSCs offer new opportunities for understanding and potentially treating incurable neurological diseases.
Supporting Evidence
- iPSCs can be derived from various cell types, including skin fibroblasts.
- Patient-specific iPSCs can model neurodegenerative diseases and may help in drug screening.
- iPSCs derived from patients with genetic disorders retain disease-specific characteristics.
Takeaway
Scientists can turn patients' skin cells into special cells that might help treat brain diseases. This could lead to new ways to help people with conditions like Alzheimer's or Parkinson's.
Methodology
The review summarizes advancements in iPSC generation, their differentiation into neural lineages, and their applications in disease modeling and transplantation.
Limitations
The study highlights challenges such as tumorigenicity, variability in iPSC lines, and the need for better differentiation methods.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website